TABLE 5.
Heterogeneity factor | Coefficient | SE | t | p-value | 95% CI (lower limit, upper limit) |
---|---|---|---|---|---|
region | 4.255238 | 2.975009 | 1.43 | 0.196 | −2.77954, 11.29002 |
year of publication | 3.702559 | 4.491461 | 0.82 | 0.437 | −6.91806, 14.32318 |
whether thestudy set the dose subgroup | 4.001104 | 5.08711 | 0.79 | 0.457 | −8.027999, 16.03021 |
in vivo or in vitro experiments | −0.779716 | 5.795373 | −0.13 | 0.897 | −14.4836, 12.92416 |
myocardial ischemia duration | 1.391345 | 2.765627 | 0.50 | 0.630 | −5.148324, 7.931014 |
times of administration | 0.21975 | 5.388646 | 0.04 | 0.969 | −12.52237, 12.961873 |
animal sample size | 2.58827 | 5.942484 | 0.44 | 0.676 | −11.46347, 16.64001 |
publication language | 3.311636 | 7.378133 | 0.45 | 0.667 | −14.13488, 20.75815 |
Cutoff value | −35.80981 | 21.23304 | −1.69 | 0.136 | −86.01798, 14.39835 |
SE, standard error; CI, confidence interval.